Lead-in or No, Switch to Long-Acting Monthly ART Is Safe Lead-in or No, Switch to Long-Acting Monthly ART Is Safe

Safety, tolerability, and efficacy of cabotegravir/rilpivirine was similar whether patients were transitioned directly or gradually onto the long-acting formulation of the drug.Medscape Medical News
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news